Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Microalbuminuria and early endothelial activation in essential hypertension

Abstract

We hypothesized that in essential hypertensive patients (EHs), plasma levels of pro-atherogenic adhesion molecules would be increased and related with urine albumin excretion (UAE). Thus, this study was aimed at evaluating biochemical markers of endothelial activation and their relationship with UAE in a group of patients with uncomplicated EH. In basal condition soluble forms of adhesion molecules intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1, as well as 24-h UAE were assayed. One hundred patients with essential hypertension and no diabetes or ultrasonographic evidence of atherosclerosis were included in the study. Seventy normotensive healthy subjects served as controls. EHs were first studied overall, than were divided into two subgroups: those with UAE 20 mcg/min MAUs and those with UAE <20 mcg/min (non-MAUs). ICAM-1 (P<0.001) and VCAM-1 (P<0.0001) plasma concentrations were higher in EHs than in controls. Microalbuminuric EHs had greater levels of adhesion molecules than non-MAUs (ICAM-1 P=0.04; VCAM-1 P=0.02, respectively). In EHs UAE was correlated with ICAM-1 (r=0.29, P=0.003), and VCAM-1 (r=0.30, P=0.002). These associations were confirmed in multiple regression models (P=0.02 for both ICAM-1 and VCAM-1) including, along with adhesion molecules, age, body mass index and blood pressures. Our findings show that in essential hypertension there is a very early activation of endothelial adhesion molecules favouring atherosclerosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on endothelin and endothelial factors of the European Society of Hypertension. J Hypertension 2005; 23: 7–17.

    Article  CAS  Google Scholar 

  2. Smith SJ . The role of integrin-mediated cell adhesion in health and disease: integrin based therapy in clinical medicine. Ann Intern Med 2000; 132: 333–336.

    Article  CAS  Google Scholar 

  3. Ross R . The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–809.

    Article  CAS  Google Scholar 

  4. Malek AM, Alper SL, Izumo S . Haemodynamic shear stress and its role in atherosclerosis. JAMA 1999; 282: 2035–2042.

    Article  CAS  Google Scholar 

  5. Taddei S, Virdis A, Mattei P, Salvetti A . Aging and endothelial function in normotensive subjects and essential hypertensive patients. Circulation 1995; 91: 1981–1987.

    Article  CAS  Google Scholar 

  6. Anderson TJ . Assessment and treatment of endothelial dysfunction in humans. JACC 1999; 34: 631–637.

    Article  CAS  Google Scholar 

  7. Blann AD, Naqvi T, Waite MA, McCollum CM . Von Willebrand factor and endothelial damage in essential hypertension. J Human Hypertens 1993; 7: 107–111.

    CAS  Google Scholar 

  8. Cottone S, Vadalà A, Vella MC, Panepinto N, Cerasola G . Comparison of tumour necrosis factor and endothelin-1 between essential and renal hypertensives. J Human Hypertens 1998; 12: 351–354.

    Article  CAS  Google Scholar 

  9. Cottone S, Mulè G, Nardi E, Vadalà A, Guarneri M, Cerasola G . Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension. Am J Hypertens 2006; 19: 313–318.

    Article  CAS  Google Scholar 

  10. Pedrinelli R, Giampiero O, Carmassi F, Melillo E, Dell’Omo G, Catapano G et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14–18.

    Article  CAS  Google Scholar 

  11. Cottone S, Vadalà A, Mangano MT, Riccobene R, Mulè G, Vella MC et al. Endothelium-derived factors in microalbuminuric and non-microalbuminuric essential hypertensives. Am J Hypertension 2000; 13: 172–176.

    Article  CAS  Google Scholar 

  12. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Sharling H et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension and diabetes. Circulation 2004; 110: 32–35.

    Article  CAS  Google Scholar 

  13. 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension – Guidelines Committee. Journal of Hypertens 2003; 21: 1011–1105.

  14. De Kossodo S, WHO Collaborative Study Group. Assaying tumour necrosis factor concentration in human serum. A WHO International Collaborative Study. J Immunol Methods 1995; 182: 107–111.

    Article  CAS  Google Scholar 

  15. Armitage P, Berry G . Statistical Methods in Medical Research, 2nd edn, Blackwell Scientific Publications: Oxford, 1987, pp 304–312.

    Google Scholar 

  16. Anderson TJ, Gerhard MD, Meredith IT . Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol 1995; 75: 71B–74B.

    Article  CAS  Google Scholar 

  17. Bitsch A, Klene W, Murtada L, Prange H, Rieckmann P . A longitudinal prospective study of soluble adhesion molecules in acute stroke. Stroke 1998; 29: 2129–2135.

    Article  CAS  Google Scholar 

  18. De Caterina R, Basta G, Lazzerini G, Dell’Omo G, Petrucci R, Morale M et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 2646–2654.

    Article  CAS  Google Scholar 

  19. Ikata J, Wakatsuki T, Oishi Y, Oki T, Ito S . Leukocyte counts and concentrations of soluble adhesion molecules as predictors of coronary atherosclerosis. Coron Artery Dis 2000; 11: 445–449.

    Article  CAS  Google Scholar 

  20. Blankeberg S, Rupprechy HJ, Bickel C, Peetz D, Hafner G, Tiret IJ . Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001; 104: 1336–1342.

    Article  Google Scholar 

  21. Malmqvist K, Wallen HN, Held C, Kahan T . Soluble cell adhesion molecules in hypertensive concentric left ventricular hypertrophy. J Hypertens 2002; 20: 1563–1569.

    Article  CAS  Google Scholar 

  22. Rosenson RS, Koenig W . High-sensitivity CRP and cardiovascular risk in CHD patients. Curr Opin Cardiol 2002; 17: 325–331.

    Article  Google Scholar 

  23. Blake GJ, Rifai N, Buring JE, Ridker PM . Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 2003; 108: 2993–2999.

    Article  CAS  Google Scholar 

  24. Sesso H, Buring J, Rifai N, Blage G, Cazano J, Ridker PM . C reactive protein and risk for developing hypertension. JAMA 2003; 290: 2945–2951.

    Article  CAS  Google Scholar 

  25. Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI . Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 2001; 19: 857–861.

    Article  CAS  Google Scholar 

  26. Sung KC, Suh JY, Kim BS, Kang JH, Kim H, Lee MH et al. High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 2003; 16: 429–433.

    Article  CAS  Google Scholar 

  27. Cerasola G, Cottone S, Mulè G, Mangano MT, Contorno A, LiVecchi M et al. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens 1996; 15: 915–919.

    Article  Google Scholar 

  28. Hillege HL, Fidler V, Diercks G, van Gilst W, de Zeeuw D, van Veldhuisen DJ et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777–1782.

    Article  CAS  Google Scholar 

  29. Gerstein HC, Mann JFE, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al., for the investigator of HOPE Study. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and non diabetic individuals. JAMA 2001; 286: 421–426.

    Article  CAS  Google Scholar 

  30. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969–975.

    Article  Google Scholar 

  31. Klausen KP, Scharling H, Jensen G, Jensen JS . New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Hypertension 2005; 46: 1–5.

    Article  Google Scholar 

  32. De Caterina R, Ghiadoni L, Taddei S, Virdis A, Almerigogna F, Basta G et al. Soluble E-selectin in essential hypertension: a correlate of vascular structural changes. Am J Hypertension 2001; 14: 259–266.

    Article  CAS  Google Scholar 

  33. Bigazzi R, Bianchi S, Campese VM . Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implication. Am J Kidney Dis 1999; 34: 973–995.

    Article  Google Scholar 

  34. Mulè G, Cottone S, Vadalà A, Volpe V, Mezzatesta G, Mongiovì R et al. Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients. J Intern Med 2004; 256: 22–29.

    Article  Google Scholar 

  35. Klausen P, Jacobsen P, Rossing K, Jensen JS, Parving HH, Feldt-Rassmussen B . Plasma concentration of VCAM-1 and ICAM-1 are elevated in patients with type 2 diabetes mellitus with microalbuminuria or overt nephropathy. Diabet Med 2000; 17: 644–649.

    Article  Google Scholar 

  36. Koga M, Otsuki M, Kubo M, Hashimoto J, Kasayama S . Relationship between circulating vascular cell adhesion molecule-1 and microvascular complications in type 2 diabetes mellitus. Diabet Med 1998; 15: 661–667.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by a grant from the Italian Ministry for University and Scientific Research (MURST).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G Cerasola.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cottone, S., Mulè, G., Nardi, E. et al. Microalbuminuria and early endothelial activation in essential hypertension. J Hum Hypertens 21, 167–172 (2007). https://doi.org/10.1038/sj.jhh.1002109

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002109

Keywords

This article is cited by

Search

Quick links